title: [Long-term non-deforming urinary infections in childhood. 2. Proposed treatment and results].
abstract: In the second part of the Authors work, they report the results obtained in the treatment of 85 female children with recurrent non malformative urinary tract infections. The first group of 15 female children had been treated with phenoxybenzamine and urinary chemyotherapycs with little satisfaction. The other two groups, both of which consisted of 35 children, one group was treated with only chemyotherapycs and the other with chemyotherapycs associated to oxybutynin chloride. The best results were obtained in the last group regarding the improvement of the symptoms and earlier and higher incidence of sterilization of the urine. At the same time in this group the maximum cystometric capacity and vesical compliance were brought back to normal and the detrusorial instability disappeared.
mesh_terms: D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D002648:Child; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use*; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D010876:Pipemidic Acid / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D008333:Mandelic Acids; D010643:Phenoxybenzamine; D009268:Nalidixic Acid; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D009582:Nitrofurantoin; D014295:Trimethoprim; D013420:Sulfamethoxazole; C005419:oxybutynin; D010876:Pipemidic Acid
vernacular_title: Le infezioni urinarie di lunga durata non malformativa in età pediatrica. II. Proposte di trattamento e risultati.